PRESERFLO MicroShunt is designed to allow draining of eye fluid and lowering of IOP in primary open-angle glaucoma patients.
Sight Sciences has enrolled first patients in the ORION clinical study that evaluates OMNI Surgical System in patients with mild-to-moderate glaucoma.
Artificial intelligence is already being used to monitor diabetic retinopathy while scientists elsewhere have shown machine learning can model to predict visual acuity. Digital technology holds immense promise, but where are the breakthroughs likely to...
GenesisCare has launched the Brainlab Mixed Reality Viewer at its Oxford centre for diagnostics, oncology and wellbeing, offering cancer patients a novel way to visualise their treatment.
UK-headquartered seed localisation company Endomag has received an extended indication in Europe for long-term use of its Magseed magnetic marker in any soft tissue to identify suspicious lymph nodes before chemotherapy and surgery.
The US Food and Drug Administration (FDA) has granted Breakthrough Status designation to EyeYon Medical’s artificial endothelial layer implant EndoArt.
Researchers at the University of California San Diego have created a microfluidic device which measures how ‘sticky’ cancer cells are and could improve prognostic evaluation of patient tumours.